ASMTL and cancer: Lower levels of ASMTL-AS1 in PTC are associated with overexpression of miR-93-3p and miR-660, alongside reduced FOXO1 levels, leading to an increased glycolysis rate that provides sufficient energy for the uncontrolled growth of cancer cells.